[go: up one dir, main page]

WO2009053750A3 - Novel crystalline and amorphous forms - Google Patents

Novel crystalline and amorphous forms Download PDF

Info

Publication number
WO2009053750A3
WO2009053750A3 PCT/GB2008/050988 GB2008050988W WO2009053750A3 WO 2009053750 A3 WO2009053750 A3 WO 2009053750A3 GB 2008050988 W GB2008050988 W GB 2008050988W WO 2009053750 A3 WO2009053750 A3 WO 2009053750A3
Authority
WO
WIPO (PCT)
Prior art keywords
amorphous forms
novel crystalline
novel
forms
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB2008/050988
Other languages
French (fr)
Other versions
WO2009053750A2 (en
Inventor
Abhay Gaitonde
Bindu Manojkumar
Sandeep Sonawane
Dattatrey Kokane
Vikas Padalkar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Generics UK Ltd
Mylan Pharmaceuticals Pvt Ltd
Original Assignee
Generics UK Ltd
Mylan Development Centre Pvt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Generics UK Ltd, Mylan Development Centre Pvt Ltd filed Critical Generics UK Ltd
Publication of WO2009053750A2 publication Critical patent/WO2009053750A2/en
Publication of WO2009053750A3 publication Critical patent/WO2009053750A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to novel amorphous and crystalline forms of the tartrate salt of tegaserod, and to processes for the preparation of these novel forms. The invention also relates to pharmaceutical compositions containing these novel forms, and to uses of said compositions to provide methods of treatingpatients suffering from gastrointestinal disorders.
PCT/GB2008/050988 2007-10-24 2008-10-24 Novel crystalline and amorphous forms Ceased WO2009053750A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2106MU2007 2007-10-24
IN2106/MUM/2007 2007-10-24

Publications (2)

Publication Number Publication Date
WO2009053750A2 WO2009053750A2 (en) 2009-04-30
WO2009053750A3 true WO2009053750A3 (en) 2009-08-06

Family

ID=40289166

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2008/050988 Ceased WO2009053750A2 (en) 2007-10-24 2008-10-24 Novel crystalline and amorphous forms

Country Status (1)

Country Link
WO (1) WO2009053750A2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006116953A1 (en) * 2005-05-02 2006-11-09 Zentiva, A.S. A method for the preparation of tegaserod and slected salts thereof
WO2008149154A2 (en) * 2007-06-05 2008-12-11 Generics [Uk] Limited Tegaserod succinate and polymorphic forms

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0297651B1 (en) 1987-06-29 1993-11-03 Duphar International Research B.V Anellated indole derivatives
HUT64023A (en) 1991-03-22 1993-11-29 Sandoz Ag Process for producing aminoguanidine derivatives and pharmaceutical compositions comprising such compounds
GB9721139D0 (en) 1997-10-07 1997-12-03 Glaxo Group Ltd Medicaments

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006116953A1 (en) * 2005-05-02 2006-11-09 Zentiva, A.S. A method for the preparation of tegaserod and slected salts thereof
WO2008149154A2 (en) * 2007-06-05 2008-12-11 Generics [Uk] Limited Tegaserod succinate and polymorphic forms

Also Published As

Publication number Publication date
WO2009053750A2 (en) 2009-04-30

Similar Documents

Publication Publication Date Title
WO2010055082A3 (en) New crystal form of sunitinib malate
WO2008132139A3 (en) New heterocyclic derivatives useful for the treatment of cns disorders
WO2008049116A3 (en) Substituted indoles
WO2009067686A3 (en) Sunitinib hemi-l-malate, polymorphs and preparation thereof, polymorphs of racemic sunitinib malate, compositins containing sunitinib base and malic acid and preparation thereof
WO2010092090A3 (en) Novel salts of sitagliptin
WO2006024024A3 (en) Solid and crystalline ibandronate sodium and processes for preparation thereof
WO2009104021A3 (en) Novel polymorphs and processes for their preparation
WO2011098582A3 (en) Novel crystalline forms of ivabradine hydrochloride
WO2007138282A3 (en) Bi-aryl or aryl-heteroaryl substituted indoles
WO2008070072A3 (en) Carvedilol forms, compositions, and methods of preparation thereof
WO2008083130A3 (en) Amorphous and crystalline form a of carvedilol phosphate
WO2010049449A3 (en) Novel salts of sunitinib
WO2007052023A3 (en) Novel compounds
WO2008088779A3 (en) Solid state forms of 5-azacytidine and processes for preparation thereof
WO2008001201A3 (en) Pharmaceutical compositions of clopidogrel
WO2008129501A3 (en) Pharmaceutical compositions of duloxetine
WO2010008735A3 (en) Solid states of o-desmethylvenlaf axine salts
WO2010070677A3 (en) A process for the preparation of prasugrel and its pharmaceutically acceptable salts thereof
WO2008021346A3 (en) Pure paliperidone and processes for preparing thereof
WO2007098273A3 (en) Novel crystalline forms of armodafinil and preparation thereof
WO2008137134A3 (en) Amorphous eletriptan hydrobromide and process for preparing it and other forms of eletriptan hydrobromide
WO2006130416A3 (en) Novel 3-spirocyclic indolyl derivatives useful as orl-1 receptor modulators
WO2010006904A3 (en) Crystalline forms of rabeprazole sodium
WO2008081268A3 (en) Pharmaceutical compositions of entacapone
WO2010079045A3 (en) Crystalline salt forms of flibanserine

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08806795

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08806795

Country of ref document: EP

Kind code of ref document: A2